People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

Researchers are a step closer to revolutionizing how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for localized ...

The Global Robotic Radiotherapy Market, valued at approximately USD 1.1 billion in 2023, is anticipated to witness a robust growth trajectory with a compound annual growth rate (CAGR) of 11.9% over ...

Cancer patients must work closely with a nutritionist to calculate their required intake of proteins, minerals, and other ...

Discover new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for ...

In the other 26% of cases, contrast MRI suggested lesion shrinkage while the MRI-linac scans showed lesion growth. Cullison ...

Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized ...

The Gauteng Department of Health (GDoH) says prostate and breast cancer patients will be assessed at Steve Biko Academic Hospital ...

It means cancer patients could soon experience slower treatment and poorer patient experience, as ITV News' Health Correspondent Rebecca Barry reports. | ITV National News ...

In a recent phase 3 trial, SBRT led to similar tumor control and survival outcomes compared with hypofractionated ...

Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...